Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 43
Filter
1.
J Cosmet Dermatol ; 23(6): 2030-2043, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38450826

ABSTRACT

BACKGROUND: Vulvovaginal atrophy (VVA) includes a wide range of conditions affecting the reproductive and urinary systems, often requiring careful evaluation and management for optimal health. AIMS: This study aims to evaluate the symptom management effects of a real time temperature-monitored non-ablative RF device for the treatment of postmenopausal Chinese women with VVA symptoms. METHODS: This pilot study involved 24 postmenopausal Chinese women with one or more VVA symptoms, who wished to remain sexually active. VHIS, VAS, and FSFI were used to track and evaluate various aspects of the patient's condition. Analyses were conducted at the end of the study to verify the statistical significance of the treatment's results. RESULTS: All patients reported substantial, statistically significant, improvements on every VVA symptom tracked. Approximately 80% of the patients reported total symptom reversal at 12-week post-treatment follow-up. CONCLUSION: This pilot study demonstrated that non-ablative, monopolar RF technology equipped with real time temperature monitoring is feasible and safe in the treatment of postmenopausal women with VVA symptoms, and efficacious at up to 12 weeks post-treatment.


Subject(s)
Atrophy , Postmenopause , Vagina , Vulva , Humans , Female , Pilot Projects , Middle Aged , Vagina/pathology , Vulva/pathology , Vulva/radiation effects , China , Treatment Outcome , Aged , Vaginal Diseases/therapy , Vaginal Diseases/pathology , Radiofrequency Therapy/methods , Radiofrequency Therapy/adverse effects , Radiofrequency Therapy/instrumentation , Monitoring, Physiologic/methods , Monitoring, Physiologic/instrumentation , Asian People , East Asian People
2.
J Cosmet Dermatol ; 23(6): 2022-2029, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38385807

ABSTRACT

BACKGROUND: Striae distensae (SD) is a challenging cosmetic condition. Ablative fractional laser (AFL) is an effective method for treating SD. Recently, fractional radiofrequency (FRF) has been shown to be a promising treatment for SD; however, few studies have shown the differences between FRF and AFL in the treatment of SD. AIMS: This study aimed to evaluate and compare the clinical efficacy and safety of bipolar FRF with 2940-nm erbium yttrium aluminum garnet (Er:YAG) AFL in the treatment of SD. PATIENTS/METHODS: Twenty volunteers with abdominal SD were enrolled in this study. One half of the abdomen was treated with 2940-nm Er:YAG AFL, whereas the other half was treated with bipolar FRF, with three sessions at 4-week intervals. Photographic evaluations of clinical improvement were conducted by two independent investigators before and after treatment, and the patients provided self-assessments. Two participants underwent three punch biopsies, one before treatment and two obtained from bilateral representative skin lesions on the abdomen 3 months following the final treatment. RESULTS: Clinical improvements were observed in SD on both sides of the abdomen after the two treatments. Post-treatment skin biopsies revealed increased thickness in the epidermis and dermis, and higher collagen and elastin density compared to those at the baseline. No statistically significant differences were observed in the clinical outcomes between the two treatment approaches. CONCLUSIONS: The efficacy and safety of bipolar FRF treatment are comparable to those of 2940-nm Er:YAG AFL treatment, providing an alternative and effective treatment for SD.


Subject(s)
Lasers, Solid-State , Striae Distensae , Humans , Striae Distensae/therapy , Lasers, Solid-State/therapeutic use , Lasers, Solid-State/adverse effects , Female , Adult , Treatment Outcome , Young Adult , Male , Abdomen , Skin/radiation effects , Skin/pathology , Radiofrequency Therapy/adverse effects , Radiofrequency Therapy/methods , Radiofrequency Therapy/instrumentation , Biopsy/adverse effects , Patient Satisfaction
3.
Clin Exp Dermatol ; 47(2): 335-342, 2022 Feb.
Article in English | MEDLINE | ID: mdl-34431555

ABSTRACT

BACKGROUND: Hidradenitis suppurativa (HS) is a devastating chronic inflammatory skin disease with frequent recurrences. Various systemic treatments and procedures have been used but the efficacy of fractional microneedling radiofrequency (FMR) has not been reported. AIM: To evaluate the clinical and histological efficacy of FMR in the treatment of HS lesions. METHODS: An 8-week, prospective, split-body, unblinded study was conducted, which enrolled 10 adult patients with mild to moderate HS to receive 3 sessions of FMR treatment biweekly. HS severity was assessed using the number and type of lesions, HS Physician Global Assessment (HS-PGA) and the modified Sartorius score (mSS). Skin biopsies were performed on participants to assess change in inflammation before and after FMR. RESULTS: Severity of HS was significantly reduced on the FMR-treated side of the body, but not on the control side. Inflammatory HS lesions were significantly reduced after 4 weeks, while HS-PGA and mSS were significantly decreased after 6 weeks. Immunohistochemistry staining showed decreased expression of inflammatory markers including neutrophil elastases, interleukin (IL)-8 and IL-17, tumour necrosis factor-α, transforming growth factor-ß1 and matrix metalloproteinases. CONCLUSION: FMR may be a viable treatment option for mild to moderate HS.


Subject(s)
Hidradenitis Suppurativa/therapy , Radiofrequency Therapy/methods , Adolescent , Adult , Age of Onset , Female , Hidradenitis Suppurativa/immunology , Hidradenitis Suppurativa/pathology , Humans , Interleukins/analysis , Male , Matrix Metalloproteinases/analysis , Needles , Pilot Projects , Prospective Studies , Radiofrequency Therapy/instrumentation , Treatment Outcome , Tumor Necrosis Factor-alpha/analysis
4.
Dermatol Surg ; 47(8): 1059-1064, 2021 08 01.
Article in English | MEDLINE | ID: mdl-34115683

ABSTRACT

BACKGROUND: Radiofrequency (RF) and high-intensity focused electromagnetic (HIFEM) technologies are used for noninvasive body shaping as standalone modalities. OBJECTIVE: To examine the effects of novel synchronized RF and HIFEM on subcutaneous adipose tissue in a porcine animal model. MATERIALS AND METHODS: Seven large white pigs aged 6 months received 3 abdominal treatments of simultaneous application of synchronized RF and HIFEM (30 minutes, once per week). Punch biopsies of treated and control subcutaneous tissue were collected at the baseline, 4 days, 2 weeks, 1 month, and 2 months. Specimens were examined by light and scanning electron microscopy. Adipocyte volume was analyzed. Fat tissue temperature was measured in situ (fiber optic probes) and superficially (thermal imager). RESULTS: Fat layer was heated to temperatures of 42 to 45°C. Signs of fat apoptosis (shape alternations and pyknotic nuclei) appeared at day 4 and peaked between 2 weeks and 1 month. Adipocyte volume decreased significantly (p < .001) by 31.1% at 2 weeks, 1 month (-23.6%), and 2 months (-22.0%). Control samples showed healthy adipocytes. Scanning electron microscopy micrographs corroborated histology findings, showing flattened, volume-depleted and disrupted adipocytes. CONCLUSION: Synchronized RF with HIFEM procedure resulted in a significant and sustained fat reduction with no adverse events.


Subject(s)
Body Contouring/methods , Magnetic Field Therapy/methods , Radiofrequency Therapy/methods , Subcutaneous Fat/radiation effects , Adipocytes/radiation effects , Adipocytes/ultrastructure , Animals , Body Contouring/adverse effects , Body Contouring/instrumentation , Combined Modality Therapy/instrumentation , Combined Modality Therapy/methods , Female , Hot Temperature/adverse effects , Magnetic Field Therapy/adverse effects , Magnetic Field Therapy/instrumentation , Microscopy, Electron , Models, Animal , Radiofrequency Therapy/adverse effects , Radiofrequency Therapy/instrumentation , Subcutaneous Fat/cytology , Subcutaneous Fat/ultrastructure , Swine
5.
J Drugs Dermatol ; 20(5): 523-528, 2021 May 01.
Article in English | MEDLINE | ID: mdl-33938689

ABSTRACT

Hyperhidrosis (HH) is defined as perspiration beyond the level required to maintain temperature regulation. HH affects nearly 4.8% of the population in the United States. It can have a great impact on patient’s quality of life by disturbing daily activity, performance, confidence, social interactions, and mental health. In the majority of patients with HH (93%), the etiology of excess sweating is idiopathic, which classifies it as primary focal HH. Mild HH may be controlled with topical antiperspirants and lifestyle modifications. Based on the location of involvement, iontophoresis and botulinum toxin may be considered if the patient does not respond to topical therapies. Despite minimizing sweating, chronic use of systemic anticholinergics, in particular oxybutynin, may result in detrimental adverse effects such as dementia. Local surgery, radiofrequency, microwave, and lasers are other potential modalities for HH. Sympathectomy can be a last resort for the treatment of focal HH of the palmar, plantar, axillary, and craniofacial areas after failure of less invasive therapeutic options. In this review, we conducted a comprehensive search in the PubMed electronic database to summarize an algorithmic approach for the treatment of HH. This can help broaden options for managing this difficult disease. J Drugs Dermatol. 20(5): doi:10.36849/JDD.5774.


Subject(s)
Dermatology/methods , Hyperhidrosis/therapy , Sweat Glands/physiopathology , Antiperspirants , Botulinum Toxins, Type A/administration & dosage , Botulinum Toxins, Type A/adverse effects , Cholinergic Antagonists/administration & dosage , Cholinergic Antagonists/adverse effects , Combined Modality Therapy/methods , Dermatology/standards , Humans , Hyperhidrosis/diagnosis , Hyperhidrosis/etiology , Hyperhidrosis/psychology , Iontophoresis/methods , Laser Therapy/methods , Practice Guidelines as Topic , Quality of Life , Radiofrequency Therapy/adverse effects , Radiofrequency Therapy/instrumentation , Radiofrequency Therapy/methods , Severity of Illness Index , Sweat Glands/drug effects , Sweat Glands/radiation effects , Sympathectomy , Treatment Outcome
7.
Dermatol Surg ; 47(6): 762-766, 2021 06 01.
Article in English | MEDLINE | ID: mdl-33899795

ABSTRACT

BACKGROUND: Aging of the face and upper neck is a complex process characterized by loss of collagen and elastic fibers, resulting in clinical skin laxity. Noninvasive interventions such as monopolar capacitively coupled radiofrequency (MRF) have gained popularity, offering a safer and more convenient alternative to traditional surgical face lift. The latest MRF device features larger tips, vibration, cooling, and impedance matching. OBJECTIVE: We performed the first open-label clinical trial, measuring the efficacy, safety, and patient satisfaction of this device for noninvasive lifting and tightening of the face and upper neck. MATERIALS AND METHODS: Forty subjects 30 to 60 years of age with mild/moderate skin laxity of the face and upper neck were enrolled. After pretreatment with ketorolac 60 mg intramuscular injection, subjects underwent treatment with MRF. Follow-up evaluations were performed on Days 30, 60, and 180. RESULTS: Our study demonstrated that the newest generation MRF produced statistically significant improvement in skin laxity 6 months post-treatment, especially in the jowls and melolabial folds. According to the Investigator Global Aesthetic Improvement Score, 73% of subjects had improvement at 6 months post-treatment. Subject satisfaction and improvement questionnaires supported these findings. CONCLUSION: Our data coupled with the excellent adverse effect profile validates MRF as an attractive treatment modality for facial and upper neck skin laxity.


Subject(s)
Cosmetic Techniques/instrumentation , Radiofrequency Therapy/instrumentation , Rhytidoplasty/instrumentation , Adult , Cosmetic Techniques/adverse effects , Esthetics , Female , Humans , Male , Middle Aged , Neck , Patient Satisfaction , Radiofrequency Therapy/adverse effects , Radiofrequency Therapy/methods , Rhytidoplasty/adverse effects , Rhytidoplasty/methods , Skin Aging/radiation effects , Treatment Outcome
8.
Dermatol Surg ; 47(6): 755-761, 2021 06 01.
Article in English | MEDLINE | ID: mdl-33577211

ABSTRACT

BACKGROUND: Many studies have evaluated radiofrequency microneedling (RFMN) in various dermatologic conditions. However, the efficacy and safety of RFMN, and how it compares with other energy-based devices in a clinician's armamentarium, remains unclear. OBJECTIVE: To review higher-quality evidence supporting RFMN and the dermatologic conditions which it can be used in. MATERIALS AND METHODS: A search was conducted in MEDLINE and EMBASE from inception to May 13, 2020, using the terms: "radiofrequency microneedling" OR "fractional radiofrequency" OR "radiofrequency needling" OR "radiofrequency percutaneous collagen induction." Only randomized, split body or blinded studies with original data on humans were included. Non-English or non-dermatology-related studies were excluded. RESULTS: Forty-two higher-quality studies were included after applying the inclusion and exclusion criteria. There were 14 studies for skin rejuvenation, 7 for acne scars, 6 for acne vulgaris, 5 each for striae and axillary hyperhidrosis, 2 for melasma, and 1 each for rosacea, cellulite, and androgenetic alopecia. CONCLUSION: Radiofrequency microneedling is an effective intervention that can be used repeatedly and safely in combination with other treatment modalities and in individuals with darker skin phototypes. Radiofrequency microneedling-induced dermal remodeling and neocollagenesis are slow and progressive but continue to improve even 6 months after treatment.


Subject(s)
Cosmetic Techniques , Dry Needling/methods , Radiofrequency Therapy/methods , Acne Vulgaris/therapy , Cicatrix/therapy , Collagen/biosynthesis , Dry Needling/adverse effects , Dry Needling/instrumentation , Humans , Hyperhidrosis/therapy , Needles/adverse effects , Radiofrequency Therapy/adverse effects , Radiofrequency Therapy/instrumentation , Rejuvenation , Skin/metabolism , Skin/radiation effects , Skin Aging/radiation effects , Skin Pigmentation , Treatment Outcome
9.
Rehabilitacion (Madr) ; 54(3): 154-161, 2020.
Article in Spanish | MEDLINE | ID: mdl-32441260

ABSTRACT

OBJECTIVE: To determine whether a multimodal rehabilitation protocol (Biofeedback [BFB] plus capacitive-resistive [INDIBA®] radiofrequency [RF]) reduces pain and increases muscular strength in patients with chronic pelvic pain (CPP) and dyspareunia. MATERIAL AND METHODS: We performed a prospective, quasi-experimental, before-after study in 37 patients with CPP and/or dyspareunia referred to the Rehabilitation Department of Hospital Universitario Santa Cristina (January 2016 to December 2018). The protocol consisted of 8 sessions of pelvic floor exercises assisted by manometric BFB (15min of tonic/phasic exercises each) supervised by a physiotherapist, followed by suprapubic and perineovaginal bipolar RF [capacitive(5 min)/resistive(10 min)]. The variables evaluated were pain (VAS 0-10) and strength (mmHg) of the pelvic floor musculature and the start/end of the treatment. RESULTS: The mean age was 41.5±12.65 years. The prevalence was higher among women aged 21-40 years (n=20, 54%) and those aged 41-60 years (n=12; 32.4%). Dyspareunia was present in 34 patients (91.8%), and non-specific CPP in 3 (8.2%). The protocol improved pain (from 7.27±1.34 to 3.75±2.21 points), maximal muscular strength (from 25.56±15.9mmHg to 35.35±20.4mmHg) and mean muscular strength (from 4.86±3.53mmHg to 7.18±4.46mmHg) respectively (p<0.0001). CONCLUSION: CPP and dyspareunia are a diagnostic challenge that requires multidisciplinary management. Treatment should be started early and should consist of distinct therapeutic modalities. The protocol of multimodal rehabilitation including BFB and capacitive-resistive RF reduces pain and improves strength in patients with CPP and dyspareunia.


Subject(s)
Biofeedback, Psychology , Dyspareunia/rehabilitation , Exercise Therapy , Pelvic Pain/rehabilitation , Radiofrequency Therapy , Adolescent , Adult , Chronic Pain/rehabilitation , Equipment Design , Female , Humans , Middle Aged , Muscle Strength , Pain Management , Prospective Studies , Radiofrequency Therapy/instrumentation , Radiofrequency Therapy/methods , Treatment Outcome , Visual Analog Scale , Young Adult
10.
J Cosmet Dermatol ; 19(5): 1086-1092, 2020 May.
Article in English | MEDLINE | ID: mdl-32233007

ABSTRACT

BACKGROUND: Postacne scars have significant psychosocial distress among patients. Subcision is a well-known treatment modality specially for rolling type of acne scars, but is a crude mechanical process, which carries a risk of hematoma formation. AIMS: To compare the efficacy and safety of radiofrequency-assisted subcision (rSubcision) with conventional subcision in postacne scars. METHODS: In this randomized, split-face study, adult patients with postacne scars were randomized to receive either conventional subcision or rSubcision in 2 sessions, 4 weeks apart and followed up for 2 months. Outcome was measured using Goodman and Baron score (GBS), investigator global assessment (IGA) by two blinded dermatologists, and patient global assessment (PGA). RESULTS: Seventeen out of 21 patients completed the treatment. Statistical analysis of the results was performed using SPSS 15.0 statistical software (SPSS). Patients in both the groups had significant improvement from baseline according to quantitative scoring (P = .0001), number of scars (P = .0001), IGA, and PGA. The improvement was comparable in both the groups according to GBS and IGA but better on rSubcision side in terms of PGA. Two patients developed small entry point burn during rSubcision which healed in one month and one developed persistent hematoma with conventional subcision. CONCLUSIONS: Both modalities were comparable in terms of assessment scores and investigator assessment, but patients found improvement better on rSubcision side.


Subject(s)
Acne Vulgaris/therapy , Cicatrix/therapy , Dermatologic Surgical Procedures/methods , Electrosurgery/methods , Radiofrequency Therapy/methods , Acne Vulgaris/complications , Adult , Cicatrix/diagnosis , Cicatrix/etiology , Combined Modality Therapy/adverse effects , Combined Modality Therapy/instrumentation , Combined Modality Therapy/methods , Dermatologic Surgical Procedures/adverse effects , Dermatologic Surgical Procedures/instrumentation , Electrosurgery/adverse effects , Electrosurgery/instrumentation , Face , Female , Humans , Male , Radiofrequency Therapy/adverse effects , Radiofrequency Therapy/instrumentation , Severity of Illness Index , Skin/radiation effects , Treatment Outcome
11.
Dermatol Surg ; 46(10): e71-e77, 2020 10.
Article in English | MEDLINE | ID: mdl-32187040

ABSTRACT

BACKGROUND: Fractional microneedle radiofrequency (FMRF) systems are popular options for treating acne scars. However, treatment efficacy when used in combination with traditional ablative fractional laser (AFL) and the safety profile with concomitant use of isotretinoin remain unknown. OBJECTIVE: The aim of this study was to assess the safety and efficacy of an early intervention combination treatment protocol for inflammatory acne and acne scars. MATERIALS AND METHODS: The electronic records of 71 patients with inflammatory acne and acne scars were included in this retrospective observational study. Data were collected for all patients who received combination FMRF and AFL. Within the study group, 43 patients were receiving low-dose isotretinoin or had completed isotretinoin within the past 3 weeks. RESULTS: The mean Scar Global Assessment score significantly decreased after 3 sessions of combination treatment (n = 71). Patients with inflammatory acne showed a significant decrease in the number of inflammatory lesions (n = 30). Patients with concomitant low-dose isotretinoin use reported a further decrease in Scar Global Assessment score (n = 43). There were no reported persistent side effects, including prolonged inflammatory reaction or scarring. CONCLUSION: Combination treatment with FMRF and AFL is an effective and well-tolerated treatment modality for acne scars and inflammatory acne.


Subject(s)
Acne Vulgaris/therapy , Cicatrix/therapy , Dry Needling/methods , Isotretinoin/administration & dosage , Laser Therapy/methods , Radiofrequency Therapy/adverse effects , Acne Vulgaris/complications , Acne Vulgaris/diagnosis , Administration, Oral , Adult , Cicatrix/diagnosis , Cicatrix/etiology , Combined Modality Therapy/adverse effects , Combined Modality Therapy/methods , Dose-Response Relationship, Drug , Dry Needling/adverse effects , Dry Needling/instrumentation , Female , Follow-Up Studies , Humans , Laser Therapy/adverse effects , Lasers, Gas/therapeutic use , Male , Needles/adverse effects , Radio Waves/adverse effects , Radiofrequency Therapy/instrumentation , Radiofrequency Therapy/methods , Retrospective Studies , Severity of Illness Index , Treatment Outcome , Young Adult
12.
J Cosmet Laser Ther ; 22(4-5): 205-209, 2020 Jul 03.
Article in English | MEDLINE | ID: mdl-33650938

ABSTRACT

Facial erythema from rosacea and acne is one of the most common problems encountered in dermatologic clinics. Effective therapeutic interventions for persistent erythema, which can cause patients frustration and psychological distress, are needed. The aim of this study was to evaluate the efficacy and safety of an invasive short pulsed-type bipolar radiofrequency device (IPBRF) for the treatment of intractable facial erythema. Thirty-one patients who had been diagnosed with rosacea or acne vulgaris and combined erythema underwent at least two IPBRF treatment sessions (maximum: 5) at 2-week intervals. Treatment outcomes were evaluated by investigator global assessment (IGA) based on clinical photographs, patient global assessment (PGA) score, and skin biophysical parameters including erythema index (EI), melanin index (MI), and transepidermal water loss (TEWL). Most patients showed significant clinical improvement. IGA scores for erythema, pores and smoothness improved after treatment. PGA also showed a trend toward improvement. Mean EI was significantly improved after the second treatment compared to baseline, which maintained until the study period. MI and TEWL showed a tendency toward improvement. There were no serious adverse events reported during the study. IPBRF led to rapid clinical improvement in facial erythema associated with rosacea and acne vulgaris and could be an effective and safe treatment option.


Subject(s)
Acne Vulgaris , Erythema/radiotherapy , Radiofrequency Therapy/instrumentation , Rosacea , Acne Vulgaris/complications , Erythema/etiology , Face , Humans , Rosacea/complications , Skin , Treatment Outcome
13.
J Cosmet Dermatol ; 19(1): 105-111, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31102325

ABSTRACT

BACKGROUND: While a considerable number of cases with papulopustular rosacea (PPR) are resistant to conventional medications, therapeutic regimens are not currently established. Pulsed dye laser (PDL) and fractional microneedling radiofrequency (FMR) have previously demonstrated satisfactory results for anti-angiogenesis, anti-inflammation, and dermal remodeling. AIMS: To evaluate the efficacy and safety of novel combination regimen with low-dose oral isotretinoin, PDL, and FMR in the treatment of recalcitrant PPR. PATIENTS AND METHODS: A retrospective study was undertaken for recalcitrant PPR patients to evaluate the clinical course of novel combination regimen. Twenty-five PPR patients who had failed in previous first-line therapies were enrolled. They were treated with three sessions of PDL and FMR consecutively at 4-week intervals, maintaining daily oral administration of 10 mg isotretinoin for 8 weeks. Objective assessments, erythema index measurement, and patients' subjective satisfaction were evaluated at each visit and 16 weeks after the final treatment. RESULTS: At the final follow-up visit, the number of papules and pustules decreased by 71%, and erythema index by 54% compared with baseline (P < 0.05 for both). Physician's global assessment based on rosacea severity score and patients' subjective assessments paralleled with these results. No serious side effect was observed during whole study periods. CONCLUSION: This novel combination regimen demonstrated satisfactory efficacy with reasonable safety profiles for the treatment of recalcitrant PPR.


Subject(s)
Isotretinoin/administration & dosage , Lasers, Dye/therapeutic use , Low-Level Light Therapy/instrumentation , Radiofrequency Therapy/instrumentation , Rosacea/therapy , Administration, Oral , Adult , Combined Modality Therapy/adverse effects , Combined Modality Therapy/instrumentation , Combined Modality Therapy/methods , Dose-Response Relationship, Drug , Female , Follow-Up Studies , Humans , Isotretinoin/adverse effects , Lasers, Dye/adverse effects , Low-Level Light Therapy/adverse effects , Male , Middle Aged , Needles/adverse effects , Patient Satisfaction , Radiofrequency Therapy/adverse effects , Retrospective Studies , Rosacea/diagnosis , Severity of Illness Index , Treatment Outcome
14.
J Cosmet Dermatol ; 19(1): 115-121, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31141299

ABSTRACT

BACKGROUND: Acne scars lead to social and psychological problems for patients, and they should be treated effectively. Ablative and nonablative lasers have been used for the treatment of acne scars in recent years. AIMS: The aim of this study was to evaluate the effectivity of combined FCL and FmRF treatment for acne scars retrospectively. METHODS: A total of 72 patients with acne scars who received FCL + FmRF treatment between 2014 and 2016 were included in this study. Photographs of patients before treatment and 1 month following the last treatment session were scored by two blinded researchers, according to the ECCA acne scar scoring method. Patients were contacted via telephone after 1 month following the last treatment and asked to evaluate their satisfaction with the treatment outcome using a 5-point Likert-type scale. RESULTS: A significant decrease was noted in ECCA scores after the treatment along with temporary side effects. Change from pretreatment scores was significantly higher in patients very satisfied vs satisfied with treatment. The number of treatment sessions was positively correlated with treatment-related change in ECCA scores. CONCLUSIONS: In conclusion, our findings revealed association of FCL + FmRF treatment with significantly improved ECCA scores, mild pain experience, and low rate of side effects in patients with acne scars, despite usage of high-energy FLC dose and five sessions of treatment on average. More remarkable improvement in ECCA scores during treatment seems to be associated with higher patient satisfaction and to be more likely in patients with darker skin types.


Subject(s)
Acne Vulgaris/complications , Cicatrix/therapy , Lasers, Gas/therapeutic use , Low-Level Light Therapy/methods , Radiofrequency Therapy/methods , Adult , Cicatrix/etiology , Combined Modality Therapy/adverse effects , Combined Modality Therapy/methods , Female , Humans , Low-Level Light Therapy/adverse effects , Low-Level Light Therapy/instrumentation , Male , Needles/adverse effects , Pain Measurement , Pain, Procedural/diagnosis , Pain, Procedural/etiology , Patient Satisfaction , Radiofrequency Therapy/adverse effects , Radiofrequency Therapy/instrumentation , Retrospective Studies , Treatment Outcome , Young Adult
16.
J Cosmet Dermatol ; 19(5): 1105-1109, 2020 May.
Article in English | MEDLINE | ID: mdl-31490628

ABSTRACT

BACKGROUND: There is a tremendous demand for dermal rejuvenation with minimal invasiveness and patient downtime. AIMS: In this study, we evaluated the performance of nonfractional monopolar radiofrequency for the improvement of photoaged skin texture and wrinkles. METHODS: In total, 32 6-week-old female hairless mice were randomized into four groups of eight mice each: (a) healthy control, (b) UVB-exposed, (c) UVB + microneedling, and (d) UVB + microneedle RF. After applying each treatment modality, skin surface was globally investigated and histologically evaluated senile skin change. Immunohistochemistry was tested with the primary antibody to collagen type I and III. RESULTS: After UVB exposure, the Ra value was significantly increased, leading to clinical development of wrinkles with xerotic scales. Depth and number of wrinkles showed gradual improvement in RF-treated mice. The mean Ra value of the RF-treated group decreased significantly. The RF-treated group showed decreased epidermal thickness, suppression of dermal inflammatory cell infiltration, and increased density of collagen fibers and amount of elastic fibers. CONCLUSIONS: Microneedle RF treatment alleviates photoaged skin texture and wrinkles in this mouse model. To the best of our knowledge, our results provide the first evidence that a nonfractional monopolar microneedle radiofrequency device may contribute to the treatment of UV-damaged skin.


Subject(s)
Cosmetic Techniques/adverse effects , Dry Needling/methods , Radiofrequency Therapy/methods , Skin Aging/radiation effects , Skin/pathology , Animals , Disease Models, Animal , Dry Needling/adverse effects , Dry Needling/instrumentation , Epidermis/pathology , Epidermis/radiation effects , Female , Humans , Mice , Mice, Hairless , Needles/adverse effects , Radiofrequency Therapy/adverse effects , Radiofrequency Therapy/instrumentation , Rejuvenation , Skin/radiation effects , Skin Aging/pathology , Ultraviolet Rays/adverse effects
18.
J Cosmet Dermatol ; 19(2): 388-392, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31829510

ABSTRACT

BACKGROUND: Application of radiofrequency (RF) energy with microneedles to facial skin shown to promote skin renewal. AIM: To evaluate the safety and efficacy of the VoluDerm technology with 100 ultra-thin electrodes gen100 tip for improvement of skin texture and wrinkles. METHODS: A prospective, open-label, intra-individual-controlled trial. Twelve subjects (mean age, 45.5; Fitzpatrick skin types II-III) with Fitzpatrick Elastosis Scale (FES) score 3-6 were treated with VoluDerm RF technology using the gen100 ultra-thin electrodes disposable tip. The participants underwent three treatments at 3-week intervals. Treatment safety was evaluated at each treatment visit and at the follow-up visits (1 and 3 months post last treatment). Efficacy of treatment evaluated at 1 and 3 months after the last treatment using the FES as well as evaluator- and subject-rated Global Aesthetic Improvement Scale (GAIS). RESULTS: Treatment was well tolerated, with no downtime or adverse events. One and three months after the last treatment session, physician-rated FES showed statistically significant improvement of 2.67 ± 1.18 and 2.33 ± 1.03, respectively (P < .0001), from baseline (4.83 ± 0.69). According to the investigator assessment of improvement using the GAIS scale, all subjects had an improvement in skin texture and pigmentation and most of the patients (91.7%) had an improvement in skin brightness, tightness, and wrinkles. CONCLUSION: This is the first study evaluating the Legend+ RF System with VoluDerm technology using the novel gen100 ultra-thin electrodes tip. This study demonstrated effective and well-tolerated treatment for improving skin texture and appearance with minimal to no downtime.


Subject(s)
Cosmetic Techniques/instrumentation , Radiofrequency Therapy/instrumentation , Skin Aging/radiation effects , Skin Pigmentation/radiation effects , Skin/radiation effects , Adult , Cosmetic Techniques/adverse effects , Elasticity/radiation effects , Electrodes , Face , Female , Humans , Male , Middle Aged , Needles , Patient Satisfaction , Prospective Studies , Radiofrequency Therapy/adverse effects , Radiofrequency Therapy/methods , Rejuvenation , Treatment Outcome
19.
Med Phys ; 47(3): 1229-1237, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31856302

ABSTRACT

PURPOSE: Continuous monitoring of patient movement is crucial to administering safe radiation therapy (RT). Conventional optical approaches often cannot be used when the patient's surface is blocked by immobilization devices. Millimeter waves (mmWaves) are capable of penetrating nonconductive objects. In this study, we investigated using mmWave technology to monitor patient surface displacements, as well as breathing and cardiac phases, through clothing and body fixtures. METHODS: A mmWave device was mounted inside the bore of a ring-based radiotherapy linear accelerator and pointed at a reflective surface on top of the couch. Measurements were obtained at displacements of 10, 7.5, 5.0, 2.5, and 1.0 mm at heights 100, 150, and 200 mm below isocenter. Submillimeter displacements were performed at a height of 200 mm. Additionally, millimeter and submillimeter displacements were measured with and without a gown and body mold placed between the surface and the sensor. The device was programmed to transmit chirp signals at 77-81 GHz. The subject's surface was detected by fast Fourier transform (FFT) of the reflected chirp signal within a rough range bin. Fine displacements within that range bin were calculated through phase extraction and phase demodulation. The displacement data were sent through two separate bandpass filters with passbands of 0.1-0.6 and 0.8-2.0 Hz to obtain the subject's breathing and cardiac waveforms, respectively. The breathing and cardiac measurements were compared to those of a Vernier Respiration Monitor Belt and an electrocardiogram (EKG), respectively, to assess validity. RESULTS: The device was able to detect millimeter and submillimeter displacements as small as 0.1 mm, as well as monitor displacement with an accuracy within 1 mm in the presence of an obstructive object. The device's breathing and cardiac waveforms exhibited a strong phase correlation between the respiration monitor belt (ρ = 0.9156) and EKG (ρ = 0.7895), respectively. CONCLUSIONS: The mmWave device can monitor surface displacements with an accuracy better than 0.1 mm without obstructions and better than 1 mm with obstructions. It can also provide real-time monitoring of breathing and cardiac waveforms simultaneously with high correlation with traditional respiratory and cardiac monitoring devices. Overall, mmWave technology demonstrates potential for motion monitoring in the field of radiation oncology.


Subject(s)
Movement , Radiofrequency Therapy/instrumentation , Radiotherapy, Computer-Assisted/instrumentation , Feasibility Studies , Heart/physiology , Humans , Respiration , Surface Properties
20.
Lasers Surg Med ; 52(5): 396-401, 2020 06.
Article in English | MEDLINE | ID: mdl-31502662

ABSTRACT

BACKGROUND AND OBJECTIVES: The selective electrothermolysis of the sebaceous glands was suggested as a novel therapeutic option for facial acne. However, there has been no randomized controlled trial to evaluate the effectiveness and safety of the monopolar radiofrequency (RF) device using single microneedle with proximal insulation. The objective of the study was to evaluate the efficacy and tolerability of intralesional electrothermolysis using monopolar RF device and proximally-insulated single microneedle in acne patients. STUDY DESIGN/MATERIALS AND METHODS: The prospective randomized controlled clinical trial was performed to treat moderate-to-severe facial acne. Subjects randomized to the treatment group received three treatments at 4-week intervals with an RF device, whereas the control group received micro-needling and extraction. For efficacy evaluation, reduction rate of acne lesions were evaluated by two independent physicians. RESULTS: Sixty-three patients completed the study and the results showed statistically significant improvement of inflammatory acne at 12 weeks. The number of inflammatory lesions was significantly reduced at 12 weeks (20.86 vs. -5.13; P = 0.03) compared with controls. CONCLUSIONS: Selective sebaceous gland electrothermolysis can be a safe and effective method of achieving consistent improvement in acne. Lasers Surg. Med. © 2019 Wiley Periodicals, Inc.


Subject(s)
Acne Vulgaris/therapy , Radiofrequency Therapy/instrumentation , Sebaceous Glands , Adolescent , Face , Female , Humans , Male , Prospective Studies , Treatment Outcome , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...